Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
28 Sep 2013 ECC 2013 Press Release: Advanced melanoma: Pooled analysis of long-term survival with ipilimumab Melanoma - Immuno-oncology
28 Sep 2013 ECC 2013 Press Release: Anti-Cancer Drug T-DM1 Benefits Women with Avanced Breast Cancer who have Failed Several Previous Treatments: Results from TH3RESA Trial Breast cancer - Anticancer agents & Biologic therapy
26 Sep 2013 European Medicines Agency Recommends a Variation to the Terms of the Marketing Authorisation for Everolimus Central nervous system malignancies - Anticancer agents & Biologic therapy
25 Sep 2013 European Medicines Agency Recommends to Extend the Indications for Ipilimumab Melanoma - Anticancer agents & Biologic therapy
24 Sep 2013 RAS Mutations Predict a Lack of Response in Patients with Metastatic Colorectal Cancer who Receive Panitumumab–FOLFOX4 Personalised medicine - Gastrointestinal cancers
23 Sep 2013 European Medicines Agency Recommends Granting a Marketing Authorisation for Radium-223 Chloride Genitourinary cancers - Anticancer agents & Biologic therapy
23 Sep 2013 European Medicines Agency Recommends Granting a Marketing Authorisation for Trastuzumab Emtansine Breast cancer - Anticancer agents & Biologic therapy
18 Sep 2013 Clinical Tool Accurately Classifies Benign and Malignant Nodules on Lung Scans of Smokers Cancer prevention
12 Sep 2013 ECC 2013 Press Release: First randomised trial of targeted cancer medicine in all tumour types - results will pave the way for personalised treatment Personalised medicine
09 Sep 2013 Dutch Study Shows that Radiation Therapy for Ductal Carcinoma In Situ Does Not Seem to Increase Cardiovascular Disease Risk Breast cancer
06 Sep 2013 Mammography with Molecular Imaging Imaging
03 Sep 2013 New Tool Enhances the Search for Genetic Mutations Translational research
30 Aug 2013 A Head-to-Head Comparison of Pazopanib Versus Sunitinib in the First-Line Treatment of Patients with Metastatic Renal Cell Carcinoma Genitourinary cancers - Anticancer agents & Biologic therapy
27 Aug 2013 ALK Rearrangement in ALK-Positive NSCLC Reflected in Circulating Tumour Cells Lung and other thoracic tumours - Translational research
26 Aug 2013 Improved Survival in Patients with Glioblastoma Following FDA Approval of Bevacizumab Central nervous system malignancies - Anticancer agents & Biologic therapy